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Peritoneal clearance of creatinine and inulin during dialysis in
dogs: Effect of splanchnic vasodilators. The peritoneal clearance
of creatinine and inulin during isotonic peritoneal dialysis was
studied in dogs before and after the administration of two vaso-
dilators: isoproterenol and glucagon. One-liter exchanges with
15-mm dwell times were used. Blood flow in the superior mesen-
teric artery was recorded with an electromagnetic flow probe and
used as an index for total splanchnic flow. Intravenous isopro-
terenol (2.4 g/min) increased blood flow by 88%, but did not
alter peritoneal clearances. When isoproterenol was given i.p.
(0.5 .tg/ml dialysis fluid), blood flow increased by 81%, and inulin
clearance rose by 26.8% (2.06 0.18 to 2.61 0.23 ml/min;P <
0.05). Creatinine clearance increased by 17.5%, from 10.94
0.32 to 12.85 0.34 mllmin (P < 0.05). When blood flow was
returned to control levels with a clamp, clearances also returned
to control levels. Glucagon given i.p. (1.0 g/ml) had no effect on
any measured variable. Glucagon given i.v. at 10 tg/min caused
blood flow to rise by 81% and inulin clearance to rise by 25%
from 1.88 0.16 to 2.35 0.19 mI/mm (P < 0.05). Creatinine
clearance did not change. When blood flow was kept constant
with a clamp, inulin clearance remained at control levels. Vaso-
dilators seem to exercise two effects in augmenting clearance of
small and middle-sized molecules: a direct permeability effect
and a blood-flow related effect, possibly in increasing the surface
area available for exchange and/or increasing permeability of the
capillary endothelium.
Clearance péritonéale de Ia créatinine et de l'inuline au cours de
Ia dialyse chez le chien: Effet des vasodilatateurs splanchniques. La
clearance peritonéale de la créatinine et de l'inuline au cours de
Ia dialyse péritonéale isotonique a été étudiée chez des chiens
avant et après l'administration de deux vasodilatateurs:
l'isoproterenol et le glucagon. Des echanges d'un litre, avec des
cycles de 15 mm, ont été utilisés. Le debit sanguin dans l'artère
mésenterique supérieure a ete enregistré au moyen d'un debit-
metre electromagnetique et utilisé comme index du debit splanch-
nique total. L'isoprotérénol intraveineux (2,4 j.gImin) augmente
le debit sanguin de 88% mais ne modifle pas les clearances pen-
tonéales. Administré par voie intra-penitonéale (0,5 ng/ml de liq-
uide de dialyse), il augmente le debit sanguin de 81% et la clear-
ance de l'inuline de 26,8% (2,06 0,18 a 2,61 0,23 mI/mm; P <
0,05). La clearance de Ia créatinine augmente de 17,5% de 10,94
0,32 a 12,85 0,34 ml/min (P <0,05). Quand le debit sanguin
est ramené a Ia valeur contrôle par clampage les clearances re-
tournent aussi aux valeurs contrôles. Le glucagon par voie intra-
péritonéale (1,0 g/ml) n'a d'effet sur aucune des variables me-
surées. Quand il est administré par voie intraveineuse a 10 ng/
mm, le debit augmente de 81% et la clearance de l'inuline de
25%, de 1,88 0,16 a 2,35 0,19 mllmin (P < 0,05). La clear-
ance de Ia créatinine ne change pas. Quand le debit sanguin est
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maintenu constant par clampage, la clearance de l'inuline n'est
pas modifée. Les vasodilatateurs semblent exercer deux effets
en ce qui concerne I'augmentation des clearances des petites et
moyennes molecules: un effet direct sur la perméabilité et un
effet dependant du debit sanguin, peut-être en augmentant la sur-
face disponible pour I'echange et/ou en augmentant Ia per-
méabilité de l'endothélium capillaire.
Although peritoneal dialysis for the treatment of
renal failure has been in widespread use for at least
two decades, the importance of splanchnic blood
flow, and hence blood supply to the peritoneal
membrane as a determinant of solute clearance dur-
ing this procedure, has received only fairly recently
experimental or clinical attention.
In 1970, Aune [1], in a study carried out in rab-
bits, reported that blood flow to the peritoneal
membrane was probably large enough to preclude
variation in the transfer of small-sized solutes from
capillary to dialysate during the course of an ex-
change. Similar conclusions, based on canine stud-
ies, were also reported in 1970 by Greene, Lapco,
and Weller [2]. Other studies, however, carried out
in dogs by Hare, Valtin, and Gosselin [3] and by
Henderson and Kintzel [4]demonstrated that ADH,
when provided either by the intravenous route in
physiologic amounts or in the dialysis fluid during
the course of an exchange, could alter the dialy-
sance of such solutes as potassium, iodide, and
urea. These investigators suggested that ADH
could influence the peritoneal transfer of solute by
decreasing the membrane area available for ex-
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change by inducing a primary reduction in splanch-
nic blood flow.
In 1973, Brown, Ahearn, and Noiph [5] adminis-
tered i.p. isoproterenol to a patient with sclero-
derma undergoing peritoneal dialysis and achieved
marked increments in creatinine peritoneal clear-
ance (67%) and urea clearance (26%). They sug-
gested that this agent was able to achieve its benefi-
cial effect by vasodilating the splanchnic vascula-
ture.
More recently, since 1976, a large number of re-
ports have appeared describing attempts in man [6-
9], dog [10], rabbit [11—13], and rat [14] to augment
the peritoneal clearance of small and middle-sized
molecules (500 to 5000 daltons) during peritoneal
dialysis by the use of vasoactive agents that might
cause splanchnic vasodilatation. A wide variety of
drugs have been used, such as isoproterenol [5, 10,
11], nitroprusside [6—9], hydralazine [7], glucagon
[12], phentolamine [7, 15], diazoxide [7], methyl-
prednisolone [13], dipyridamole [16], dopamine [10,
15], histamine [14], bradykinin [14], and gastroin-
testinal polypeptides [17].
In general, it has been demonstrated that most,
but not all of these agents, can increase modestly
the clearance of both small-sized molecules such as
urea (60 daltons) or creatinine (113 daltons) and
middle-sized molecules such as inulin (5200 dal-
tons). The evidence, however, that such increments
in transperitoneal transfer of solute is due to con-
comitant increments in splanchnic blood flow, is
completely inferential. For in each of the studies al-
luded to above, splanchnic blood flow has not been
recorded, and therefore, the conclusion that there
exists an association between increased splanchnic
flow and augmented peritoneal clearance is not war-
ranted. Indeed, vasoactive agents could be ex-
ercising their effects through nonspecific per-
meability changes in the peritoneal membrane.
In the present study, we observed the changes
which occurred in the peritoneal clearance of creati-
nine and inulin while administering splanchnic
vasodilators and recording changes in blood flow.
We also determined peritoneal clearances while the
vasoactive agents were present, and while blood
flow changes were prevented with an aortic clamp.
Creatinine was chosen as a representative small
molecule; and inulin, as a "middle-molecule." We
also took advantage of this model to determine
whether the clearance of a commonly ingested
drug, salicylate, could be augmented with splanch-
nic vasodilators.
Methods
Short-term studies were performed on dogs of ei-
ther sex weighing between 15 and 20 kg. They were
fasted overnight, but allowed water ad Jib. On the
morning of the experiment, anesthesia was carried
out with sodium pentobarbital (Nembutal, 25 mgi'
kg, i.v.), with small supplements given as neces-
sary. A cuffed endotracheal tube was inserted, and
ventilation provided with a Harvard animal respira-
tor. Arterial blood pressure was monitored by mer-
cury manometry through a femoral catheter pushed
into the abdominal aorta. Arterial blood samples
were taken through a PE-240 catheter placed in the
contralateral femoral artery. PE- 190 tubings were
placed into each femoral vein for the administration
of infusions as required.
The animals were prepared for acute peritoneal
dialysis in the following manner. A midline incision
was made with an electrocautery to minimize bleed-
ing. The ureters were identified and ligated. The in-
ferior mesenteric artery was identified and ligated.
The superior mesenteric artery (SMA) and celiac
axis were identified, and electromagnetic flow
probes of appropriate size were placed about either
one or both vessels. Previous experiments from our
laboratory [18] have indicated that ligation of the
inferior mesenteric artery does not influence the to-
tal splanchnic blood flow in the dog, presumably be-
cause of collateral flow in these vessels. The flow
probes were calibrated for electronic zero and were
direct-reading. Blood flow, therefore, was mon-
itored directly on a Statham SP 2202 flowmeter.
From time to time, the probes were independently
calibrated and found to agree within 5% with di-
rect readout values. In the large majority of experi-
ments, blood flow was recorded only from the
SMA. A large-bore peritoneal-dialysis catheter was
then inserted into the peritoneal cavity so that its tip
lay free in the pelvic gutter. The abdominal muscles
were then thoroughly cauterized to prevent bleed-
ing. The parietal peritoneum then was closed care-
fully with sutures, and the remainder of the wound
was closed carefully in three layers. Great care was
taken to see that the visceral peritoneum and mes-
entery was not damaged and that there was no fluid
leak about the catheter. Any leak of dialysis fluid or
persistent bleeding caused us to reject the animal
from the experimental protocol.
The fluid used had the following composition (in
milliequivalents per liter): sodium, 143; chloride,
119; bicarbonate, 24; potassium, 3.7. The os-
molality was 280 mOsmlkg, and the pH of the solu-
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tion was brought to 7.45 by adding small amounts of
1.0 N hydrochloric acid. Glucose was omitted from
the solution. Following all surgical manipulation
and closure of the wound, 1.0 liter of the dialysis
solution was quickly flushed in to clear the catheter,
remove small amounts of blood, and test for leaks.
During the experiment proper, 1000 ml of dialysis
fluid, warmed to 370 C, was allowed to run in quick-
ly under gravity. This usually took 3 to 5 mm, the
dwell time was kept at 15 mm, and then the fluid
was removed by gentle suction. The drainage phase
was usually 4 to 5 mm, and so the total dialysis time
per cycle usually ranged from 21 to 24 mins. Gener-
ally, three control cycles were performed, followed
by three experimental cycles where a vasoactive
drug was administered either i.v. or in the dialysis
fluid. Two recovery cycles ended the experiment.
To measure the peritoneal clearance of creati-
nine, we gave 1.0 g of creatinine in 30 ml of warm
saline i.v. as a bolus infusion. At least 15 mm was
allowed before any exchange was started. To mea-
sure inulin clearance, we gave 30 ml of a 2.5 g'lOO
ml solution as an i.v. bolus, followed by constant
i.v. infusion throughout the experiment at 12.5 mgI
mm. Concentrations of these substances reached
levels in the plasma and dialysate easily measurable
by our analytic techniques, even towards the end of
the experiment.
Peritoneal clearances were calculated as follows:
CdVdPeritoneal clearance = Pt
where peritoneal clearance was measured in millili-
ters per minute, Cd was concentration of substance
in dialysate (mg/100 ml), Vd was total volume of
dialysate recovered (ml), P was concentration of
substance in plasma (taken at midpoint of ex-
change; mg/l00 ml), and t was total exchange time
(mm).
In some experiments, it was necessary to reduce
splanchnic blood flow to control levels once this
variable had been increased by the introduction of
vasodilators. To achieve this, we placed a long
piece of umbilical tape about the abdominal aorta,
just below its emergence from the diaphragmatic
muscles. The ends of the tape were slipped through
a stout piece of teflon tubing and the ends brought
to the outside of the abdominal wound. By putting
tension on the tape against the teflon tubing, one
could vary splanchnic flow at will, using the
flowmeter as a guide.
The vasoactive drugs tested in these experiments
were glucagon and isoproterenol.1 Glucagon was
administered i.v. at 10 jsg/min (0.5 mllmin in isoton-
ic saline) or i.p. at 1.0 g/ml of dialysis fluid. Isopro-
terenol was given i.v. at 2.4 gImin (0.5 ml/min in
isotonic saline) or i.p. at 0.5 gIml dialysis fluid.
When isoproterenol was given i.v., no experimental
exchanges were started until the splanchnic blood
flow had reached a new stable level for at least 5
mm. Similarly, in the recovery phase, no dialysis
was started until the blood flow had declined to ap-
proximately control levels. When it was given i.p.,
blood-flow in the SMA reached augmented levels
almost at once, and dialysis was therefore started
immediately.
During each exchange, the abdomen was agitated
frequently during the dwell time to ensure good
mixing. The dead space of the dialysis catheter was
negligible (2.5 ml) compared to the volume of the
dialysate and was ignored in the calculations.
To keep the animal warm, at the end of all surgi-
cal manipulation, we wrapped the dog in a CFP
Homeothermic blanket (Ealing Scientific Co., Mon-
treal, Quebec; model 8142), and body temperature
was maintained constant at 37.9 to 38.0° C.
When the effects of dialysis on salicylates were
studied, sodium salicylate (150 g/kg in 100 ml of
normal saline) was administered i.v. over a 20-mm
period, and exchanges were taken during a control
period and again following the i.p. administration of
isoproterenol in doses listed above. Blood and
dialysate pH were monitored throughout the study
to ensure that pH gradients were not influencing
movement of salicylate into the peritoneal dialysate
by nonionic diffusion. A sample of arterial blood
was taken at the midpoint of each cycle for pH mea-
surement on a Corning model-165 blood pH/gas an-
alyzer. An aliquot of dialy sate was taken both at the
midpoint and at completion of each cycle for pH
measurement on a Fisher Accumet 230A pH meter.
The methods in use in this laboratory for the anal-
ysis of inulin, electrolytes, plasma protein, and he-
matocrit have all been described previously [19].
Salicylates were analyzed colorimetrically by the
method of Trinder [20]. Plasma and dialysate creati-
Glucagon was administered as the crystalline hydrochloride
(Eli Lilly & Co., Toronto), and isoproterenol was given as the
aqueous hydrochloride (Isuprel, Winthrop Laboratories, Auro-
ra, Ontario). The diluent provided with glucagon was not ef-
fective in either increasing splanchnic blood flow or altering pen-
toneal clearances.
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nine were measured by standard autoanalyzer tech-
niques, and osmolality was measured on an Ad-
vanced Instruments osmometer. Preliminary stud-
ies indicated that neither glucagon nor isoproterenol
in the doses used interfered with the colorimetric
analysis of creatinine or inulin.
Data were analyzed for significance with Stu-
dent's t test for paired data. P < 0.05 was accepted
as the limit for statistical significance.
Results
Validation of experimental protocol. During the
conduct of these experiments, it was necessary to
surgically incise the parietal peritoneal membrane
to permit placement of the electromagnetic flow
probes about the splanchnic vessels. It was also
necessary to operate these probes while the perito-
neal space was distended with 1 .0 liter of dialysis
fluid. Accordingly, in preliminary experiments, we
compared in eight anesthetized dogs the peritoneal
clearances for inulin and creatinine when the dial-
ysis catheter was placed by percutaneous puncture,
compared to the clearances when the catheter was
placed following laparotomy. At least three ex-
changes were performed under each condition. The
mean clearances for inulin and creatinine in the
"laparotomy" exchanges were 1.88 0.16 and 7.14
0.33 mllmin, respectively. For the "puncture"
exchanges, the values were 1.81 0.23 and 7.26
0.44 mllmin, respectively. These values are not sig-
nificantly different (P > 0.05).
In the same eight dogs, blood flow in the SMA
was measured before and after instilling 1.0 liter of
fluid into the peritoneum. Blood flow averaged
254.2 23 mllmin in the control state, and 247.4
28 mllmin when dialysis fluid was present in the
peritoneum. These values are not significantly dif-
ferent (P > 0.05). Moreover, blood flow values re-
mained constant over a prolonged time interval,
while fluid was in the peritoneum. To assess wheth-
er the flow probe would respond to alterations in
flow while peritoneal fluid was present, we con-
stricted arbitrarily the abdominal aorta in four of
these animals so that femoral arterial blood pres-
sure declined from an average of 126 6 to 80 4
mm Hg (P <0.05). SMA blood flow declined from
an average of 248 24 to 170 18 mllmin (P <
0.05).
In four other dogs, the response of the flow probe
about the SMA was compared when the splanchnic
vasculature was dilated with i.v. isoproterenol 2.4
gImin before and after the distension of the perito-
neum with dialysis fluid. Control flow in the "dry"
state averaged 240 24 mllmin, and this increased
to 460 33 mllmin following the vasodilator, an in-
crement of 91%. In the "distended" state, control
flow averaged 244 20 mllmin and increased to 450
31 mllmin; an increment of 84%. These in-
crements are not significantly different (P > 0.05)
from each other, and therefore the flow probe accu-
rately gauged increments in splanchnic blood flow
when peritoneal dialysate was present.
For the sake of convenience during the experi-
mental protocols, we monitored blood flow only in
the SMA and used this as an index for total splanch-
nic flow. To test the validity of this hypothesis, we
measured blood flow in the celiac axis and SMA
flow concurrently in response to either i.v. or i.p.
isoproterenol as used in these studies. For i.v.
isoproterenol, flow in the celiac axis increased
from 260 31 to 478 33 mllmin (84%); and in the
SMA, blood flow increased from 220 18 to 413.6
29 mllmin (88%). These increments are not signif-
icantly different from each other (P > 0.05). For
i.p. isoproterenol, flow in the coeliac axis increased
from 233 29 to 435.7 34 mI/mm (86.5%), and in
the SMA the increase was from 202 18 to 381.8
27 mllmin (89%). These increments are also not sig-
nificantly different from each other, and thus it is
valid to use only the SMA probe as an index for
changes in splanchnic blood flow.
In three dogs, the peritoneal clearance of creati-
nine and the peritoneal clearance of inulin was mea-
sured during successive cycles over a period of time
usually equivalent to that required to perform our
studies. In both animals, the peritoneal clearances
of creatinine and inulin remained constant through-
out all eight cycles (Fig. 1). Arterial blood pressure
was not influenced by different phases of the dial-
ysis cycle, and it remained constant throughout the
period of observation.
The data obtained in Fig. 1 indicate that two po-
tential sources of error, namely, the relatively short
dwell times and the fact that plasma creatinine
could be dropping precipitously following the bolus
infusion, were not contributing to spurious mea-
surements. If they were, we should not expect the
constancy in clearance measurements obtained
over an eight-cycle experimental period. In fact, the
plasma creatinine concentration dropped slowly
over the 3 hours required to perform the average
experiment. During the first cycle, plasma creati-
nine averaged 8.96 0.19 mgIlOO ml and dropped to
only 6.48 0.22 mg/100 ml for the last cycle (N =
51 dogs). Presumably, because there were no gb-
merular losses of creatinine in this study (ureters
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Cycle number
Fig. 1. Peritoneal clearances of creatinine and inulin in un-
treated dogs (N = 3) during eight successive cycles.
were ligated) and because creatinine can penetrate
the intracellular water, losses of creatinine into the
peritoneal dialysate were more or less matched by
replenishment of extracellular stores from the intra-
cellular space. In fact, on the average, plasma
creatinine concentrations rarely declined by more
than 0.5 mg/100 ml from the midpoint of one cycle
to the next.
The 15-mm dwell time appeared adequate for our
purposes, and sufficient solute was obtained, even
in later cycles, to ensure analytical accuracy. The
mean creatinine concentration in the dialysate for
the 51 dogs studied averaged 1.59 0.01 mgIlOO ml
for the first cycle and 0.99 0.02 mg/100 ml for the
last cycle. For inulin, dialysate levels averaged
8.5% of the mean plasma concentration. No experi-
mental period was encountered where there was in-
sufficient solute in the dialysate for accurate analy-
sis.
Exchange times and dialysis volumes. The range
for total exchange times varied within very narrow
limits in each phase of the experiment. For each in-
dividual dog, the variation was never more than 2
mm. Between dogs (N = 51), the range for ex-
change times varied only between 20 and 24 mm,
with a mean of 21.9 0.02 mm for each phase of the
experiment.
The recovery volumes varied between 900 and
1020 ml for 51 dogs and averaged 985.4 5.0 ml.
For any given dog, the volume of dialysate returned
never varied by more than 40 ml or 4% of the
volume instilled.
Exchanges with isoproterenol. In eight dogs,
peritoneal exchanges were obtained following the
i.v. infusion of isoproterenol at 2.4 g/min. Within 5
mm after starting the infusion, splanchnic flow rose
from a mean of 238 21 to 446 19 mllmin, an
increment of 87% (P < 0.01). Blood pressure fell
slightly, but significantly, from 130 3 to 120 2.6
mm Hg during the drug infusion. The increment in
blood flow remained fairly steady as long as the
isoproterenol infusion continued. Following cessa-
tion of the infusion, blood flow returned to control
levels within 25 to 35 mm, as did arterial blood pres-
sure. Plasma protein concentration, hematocrit, os-
molality, and plasma sodium concentration re-
mained constant throughout the study.
Figure 2 summarizes the clearances obtained for
both inulin and creatinine during control, experi-
mental, and recovery periods. During i.v. infusion,
isoproterenol had no influence on the clearances of
either compound, despite the large increments in
SMA flow.
Figure 3 summarizes the data obtained in seven
dogs, where the isoproterenol was administered i.p.
along with the dialysis fluid, at a concentration of
0.5 j.gIml. Splanchnic blood flow increased within 1
mm after the instillation of fluid was complete and
remained constant throughout the remainder of
"isoproterenol" exchanges. Clearances during the
first experimental exchange period were not statisti-
cally different from values obtained during the sec-
ond and third exchanges. Blood pressure declined
from 133 3.3 to 125 2.9 mm Hg during the ex-
perimental periods. Plasma protein concentration,
hematocrit, osmolality, and plasma sodium concen-
tration remained constant throughout the period of
observation. Following the last experimental ex-
change, it took about 20 to 25 mm for the blood flow
and arterial pressure to return to control levels. At
that time, recovery exchanges were instituted.
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Fig. 2. Peritoneal clearances during iv. isoproterenol. Note con-
stancy of clearances despite marked increments of splanchnic
blood flow.
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The data in Fig. 3 show that, unlike i.v. isopro-
terenol, i.p. provision of the drug increases signifi-
cantly the clearances of both inulin (26.8%) and
creatinine (17.5%; P < 0.05). The inulin-to-creati-
nine ratio remained constant, however, changing
from 0.19 to 0.20 (P > 0.05). A representative ex-
periment is presented in Table 1.
In three dogs, we reversed the order of the exper-
iments, so that isoproterenol exchanges were car-
ried out first and last, with control exchanges car-
ried out in the middle. These data are shown in Fig.
4 and confirm that i.p. isoproterenol will increase
the peritoneal clearances of both creatinine and in-
ulin, when the sequence of drug administration is
reversed.
Because i.v. isoproterenol did not influence pen-
toneal clearances (though blood flow increased), it
500
. 400
300
U)
200
Fig. 4. Peritoneal clearances during reverse sequence exchanges
with i.p. isoproterenol. Note that magnitude of clearances de-
pends on whether the vasoactive agent is present or not, and does
not depend on random fluctuations.
was remotely possible that the disposition of this
drug was different when given by this route, as com-
pared to the i.p. route, and that peritoneal clear-
ances of inulin and creatinine did not increase sim-
ply because there was insufficient drug available.
Accordingly, in two dogs, we doubled the rate of
i.v. administration to 4.8 xg/min. SMA flow rose
from 240 29 to 520 33 mI/mm on the average,
but blood pressure declined to 105 2 mm Hg,
from 128 3 mm Hg. Peritoneal clearance of inulin
and creatinine remained unchanged. Apparently
then, the differences observed between the Lv. and
the i.p. routes are not due to differences in drug ex-
cretion, metabolism, and so forth.
Low-dose i.p. isoproterenol. In four dogs, we ad-
ministered i.p. isoproterenol in the highest dose that
would not cause any increment in SMA blood flow.
Table 1. Eifects of i.p. isoproterenol on the exchange of creatinine and inulin in a representative dog
Dialysis
Exchange
time
fluid
ml
-___________
Cd
mg/lOOm!
P
mg/lOOm! Per. C. Per. C
SMA
flow
Blood
pressure
Cycle mm In Out Creatine Inulin Creatinine Inulin ml/min mi/mm Cin/Ccr mI/mm mm Hg
Control
1 20 1000 990 1.5 2.3 6.67 46.0 11.1 2.48 0.22 195 120
2 20 1000 960 1.5 2.3 6.23 46.8 11.6 2.36 0.20 215 125
3 21 1000 950 1.4 2.4 6.10 44.8 10.4 2.42 0.23 200 127
Experimental
4 20 1000 980 1.60 2.70 5.89 48.1 13.3 2.80 0.21 430 110
5 20 1000 990 1.62 3.00 5.51 47.0 14.6 3.16 0.21 410 110
6 20 1000 1009 1.60 3.00 5.43 46.0 16.1 3.55 0.22 390 115
Recovery
7 22 1000 960 1.33 2.80 5.40 47.0 10.7 2.60 0.24 213 120
8 20 1000 980 1.19 2.70 5.33 49 11.1 2.70 0.24 210 122
Abbreviations are: Cd, concentration of solute in dialysis fluid; P, concentration of solute in plasma; Per. C, peritoneal clearance of
creatinine; Per. C1, peritoneal clearance of inulin; SMA, superior mesenteric artery.
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Fig. 3. Peritoneal clearances during i.p. isoproterenol.
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Fig. 5. Peritoneal clearances with i.p. isoproterenol, showing
variance with the magnitude of the splanchnic blood flow.
This varied from 0.10 to 0.20 iigIml. Under these
conditions, no effect on peritoneal clearances of
creatinine or inulin was detected in the presence of
the vasoactive agent.
Aortic clamp experiments. In seven dogs given
i.p. isoproterenol, we determined the peritoneal
clearances of creatinine and inulin while controlling
the SMA blood flow with an aortic clamp. These
data are summarized in Fig. 5. Return of the blood
flow to control levels returns the peritoneal clear-
ances to baseline levels as well. Ratios of peritoneal
clearances of inulin to that of creatinine remained
constant throughout each phase of the study. A rep-
resentative experiment is summarized in Table 2.
Exchanges with glucagon. Figure 6 displays the
data obtained for eight dogs given i.p. glucagon at
1.0 g/ml and for 17 dogs given glucagon i.v. at 10
j.g/min. When given i.p., glucagon had no effect on
either splanchnic blood flow or clearances. When
the concentration of glucagon was increased to lev-
els as high as 6 tg/ml, inconstant effects were ob-
served only on SMA flow, without any effect on
clearances. In those dogs where SMA flow did in-
crease, the change was of the same order of magni-
tude as that seen in those dogs given glucagon i.v.
Thus, of seven dogs given this higher dosage i.p.,
three showed no change in SMA flow, whereas the
average increment for the remaining four dogs was
78.8% (220 24 to 394 29 mllmin). With the i.v.
glucagon, there was no effect on creatinine clear-
ance (P > 0.05), but inulin clearance rose by 25%,
from 1.88 0.16 to 2.35 0.19 ml/min (P < 0.05).
When blood flow was controlled with an aortic
clamp, similar to the experiments shown in Fig. 5,
the peritoneal clearance of creatinine remained un-
changed, and the peritoneal clearance of inulin fell
to 1.89 0.17 mllmin.
Salicylates. Figure 7 shows the effects of increas-
ing SMA blood flow with i.p. isoproterenol on both
inulin and salicylate clearances in five dogs. Both
peritoneal clearances of inulin and salicylate in-
creased significantly in response to the vasodilator.
Table 2. Effect of aortic clamping on peritoneal clearances of creatinine and inulin during i.p. isoproterenol administration'
Dialysis
fluid
Exchange ml
time
Cd
mg/lOOml
P
mgIlOOml
Per. Ce., Per. C1,,
SMA
flow
Blood
pressure
Cycle mm In Out Creatinine Inulin Creatinine Inulin mi/mm mi/mm mi/mm mm Hg
Control
1 20 1000 950 1.63 2.14 5.50 33.6 14.1 3.02 212 110
2 20 1000 960 1.62 2.16 5.43 34.0 14.3 3.05 220 112
3 20 1000 955 1.60 1.90 5.10 32.0 15.0 2.84 202 110
Isoproterenol i.p.
4 20 1000 990 1.74 2.89 4.94 34.8 17.4 4.10 440 90
5 21 1000 990 1.73 2.81 4.80 34.7 17.0 3.82 450 95
6 20 1000 980 1.75 2.81 4.6 36.0 18.6 3.82 408 95
Isoproterenol + aortic clamping
7 21 1000 960 1.44 2.63 4.50 37.0 14.7 3.26 232 100
8 20 1000 985 1.41 2.34 4.40 37.8 15.4 2.98 210 105
9 20 1000 980 1.39 2.09 4.40 37.3 15.4 2.74 220 105
Isoproterenol + release clamp
10 20 1000 975 1.62 2.77 4.1 36.0 19.2 3.75 390 100
11 20 1000 970 1.60 2.74 3.9 37.7 19.9 3.52 400 100
a Abbreviations are defined in Table 1.
Control
Control Blood flow blood flow Blood flow
Control Glucagon p. Control Glucagon iv. Recovery
(N=8) (N—17)
Fig. 6. Peritoneal clearances with i.p. or iv. glucagon. Peritoneal clearance of creatinine remains constant with iv. administration
despite large increments in splanchnic blood flow.
Salicylate clearance increased from a mean of
5.61 0.18 to 6.93 0.20 mi/mm, an increment of
23% (P < 0.05).
The dogs tolerated the salicylate infusion quite
well. One dog became hyperthermic (42° C) and be-
gan to hyperventilate; the data from this animal are
not included in the study.
Blood pH in the control phase of the experiment
was 7.39, declined to 7.19 while isoproterenol was
administered (due to the presence of salicylates),
and rose to 7.20 in the recovery phase. The pH of
the dialysate remained constant at 7.35 for each pe-
riod. Although the dialysis fluid was more alkaline
than the blood during the experimental period, the
relationships in pH between the two compartments
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Fig. 7. Peritoneal clearance of salicylate with i.p. isoproterenol.
were similar in the last two phases of the experi-
ment. Yet, only when vasodilators were given did
salicylate clearance increase. We therefore feel
that this increment was largely due to the vasoac-
tive agent, rather than an effect of nonionic dif-
fusion. There may have been some effect from the
latter phenomenon, however, because in two of five
dogs, salicylate clearance in the recovery period re-
mained significantly greater than that in the control
value, though less than with isoproterenol present.
Discussion
The administation of parenteral vasodilators
could have, theoretically, several different effects
on peritoneal clearance of solute during the course
of dialysis. First, the drug could exercise a non-
specific irritative effect to increase peritoneal per-
meability, unrelated to any vasoactive property.
Second, the drug—unrelated to any vasoactive
property—could influence permeability by a direct
effect on size or configuration of pores or channels
located in capillary endothelium or mesothelial
membrane [21]. Last, the increase in peritoneal per-
meability could be related to the vasoactive effect of
the agents concerned, namely, augmentation of
splanchnic blood flow.2 Such an effect could be me-
2 We have assumed during the course of these studies that
blood flow to the peritoneal membrane increases as splanchnic
blood flow increases. We have, however, avoided directly equat-
ing increased splanchnic flow with increased 'exchanging mem-
brane" flow, because, as Nolph points out in a recent review
[21], flow per membrane area may actually decrease. Vasodilata-
tion is most likely associated with an increase in total surface
area of membrane perfused rather than an increase in flow per
effective capillary pore. The possibility, however, that in-
crements in peritoneal capillary flow do not accompany an in-
crement in splanchnic blood flow should be kept in mind.
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diated by increased delivery of solute [22], an in-
crease in the surface area available for exchange
[21], or a flow-related increase in permeability due
perhaps to stretching of the capillary endothelium
[II, 23], or stretch on the mesothelium because of
an engorged vasculature [24, 25]. Certainly, Nolph
et al [21] have demonstrated in the rat peritoneum
that the topical application of vasodilators such as
nitroprusside not only increases enormously the
size of arterioles (vasodilatation) and the number of
smaller branches that can be seen, but also in-
creases the number of visible capillaries, suggesting
that the membrane area available for exchange may
also increase. Current theory of transperitoneal sol-
ute diffusion, discussed in great detail elsewhere
[21, 22, 26], suggests that if small, highly diffusible
solutes are flow-dependent in reaching equilibrium
within the peritoneal dialysate, then splanchnic
vasodilatation should primarily improve the clear-
ance of these substances, and not that of larger
molecules such as inulin. If, however, splanchnic
vasodilatation is accompanied by increments in sur-
face area and/or alterations in peritoneal per-
meability, then it is the clearance of the larger mole-
cules which should predominantly increase.
With these considerations in mind, let us consider
our results with isoproterenol. When this drug was
administered i.v. at 2.4 g/min, there was a marked
increment in splanchnic blood flow, but no change
in peritoneal clearances of creatinine or inulin.
Thus, large variations in splanchnic flow by itself
were not sufficient to alter peritoneal permeability
to these two solutes. When this agent was instilled
i.p. at 0.5 sgIml, splanchnic flow increased by the
same order of magnitude as when it was given i.v.,
and now both peritoneal clearances of creatinine
and inulin increased significantly, though the C111!
ratio remained constant. Controlling blood flow
with an aortic clamp returned the clearances to
baseline levels. In this situation, therefore, the
clearance of solute did depend upon variation in
splanchnic flow. That the observed increments in
clearances of creatinine and inulin with i.p. isopro-
terenol were not due to nonspecific irritative effects
or direct permeability effects by themselves may be
deduced from at least two observations. First, be-
cause there is no reason to believe that isoprotere-
nol did not diffuse into the peritoneal fluid from the
vascular space, it should be noted that with i.v. in-
stillation, no effect on solute transfer occurred. Sec-
ond, during the clamping experiments, although the
drug was present in the dialysate, clearances, pre-
viously elevated, returned to control levels. When
isoproterenol was instilled i.p. in doses just short of
that required to elevate splanchnic blood flow, no
changes in peritoneal clearances occurred. Because
neither permeability effects themselves or hemo-
dynamic effects themselves can alone be used to ex-
plain the observed data, it seems reasonable to
speculate that both effects combined must be pres-
ent before the drug will increase peritoneal clear-
ances. Any such speculation would have to satisfy
the following points: (a) isoproterenol is not ef-
fective from the vascular side of the membrane de-
spite large increments in splanchnic blood flow, (b)
isoproterenol is effective from the peritoneal side,
but only when blood flow is allowed to increase, (c)
the clearance ratio for inulin/creatinine remains un-
changed after vasodilation.
The explanation most likely to satisfy all of these
observations is that overall pore area changed,
without any predominant solute-delivery or per-
meability effect. For increased exchange area to
permit increased peritoneal clearances, two effects
are necessary: the first, apparently from the perito-
neal side, must act on the mesothelium; the second,
from the vascular side, must act to increase capil-
lary endothelial pore area by flow-related mecha-
nisms. Thus, even though local drug concentrations
may be adequate when supplied by the i.p. route to
alter permeability, augmentation of total capillary
flow and/or perfusion pressure appear to be neces-
sary to unmask or optimize the altered effect on
peritoneal clearances. Action on the capillaries
alone, or the mesothelium alone, to increase overall
pore area of those individual structures would not
be sufficient. The explanation advanced is in keep-
ing with current tenets of "pore theory," and we
make no attempt here to define exactly the limiting
resistance to solute transfer within the peritoneal
membranes.
Why i.v. isoproterenol is ineffective in improving
peritoneal clearances of creatinine and inulin,
whereas i.p. administration is quite efficacious, is
not clear from our experimental data. It may be
nothing more than that this latter route of adminis-
tration delivers concentrated amounts of the drug to
the mesothelial membrane. It must be noted, how-
ever, that other investigators performing peritoneal
dialysis in the dog [10] have also observed that i.p.
isoproterenol is effective in changing solute clear-
ance, whereas i.v. isoproterenol is not. It does not
seem reasonable to suppose that this drug would
not diffuse into the peritoneal fluid, assuming that
the drug required access to the inner surface of the
mesothelial membrane to be effective, and this sup-
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ports the view that local concentrations may be
quite important. Alternatively, we cannot empha-
size strongly enough that an increment in splanch-
nic blood flow need not be associated with an in-
crement in peritoneal capillary flow. It is entirely
possible that i.v. isoproterenol in augmenting
splanchnic blood flow does so, in part, by shunting
blood away from the exchanging area of the perito-
neal membrane, whereas i.p. isoproterenol man-
ages to increase flow both to the intestines and to
the peritoneum.
When i.v. administration of isoproterenol was in-
creased to 4.8 /Lg/min, despite further elevation of
splanchnic blood flow (and further decrement of ar-
terial pressure), no effect on peritoneal clearances
was observed. It therefore seems unlikely that i.v.
administration of the drug, as opposed to the i.p.
route, is associated with unusual metabolic dis-
posal. Recently, Maher et al [11] demonstrated that
this agent deteriorates on standing for about 60 mm,
when exposed to the atmosphere and light. Even if
some nonvasoactive property of the drug were
being compromised by deterioration during the
course of i.v. administration, considering its effica-
cy in elevating splanchnic flow, this in fact would
strengthen our argument—namely, that alterations
in peritoneal clearance cannot be effected solely by
alterations in splanchnic blood flow.
Can the results obtained with glucagon be inter-
preted in a similar fashion? When this polypeptide
was administered i.p. in doses of 1.0 jg/ml, no ef-
fect was seen on either clearances or splanchnic
blood flow. Considering its molecular weight of
3500 daltons, we might, however, anticipate poor
diffusion into the vascular space [12]. At higher
doses (6 g/ml), some dogs showed marked in-
crements in blood flow, but no change in clear-
ances. When this substance was administered i.v.,
splanchnic blood flow increased by an order of mag-
nitude similar to that observed with isoproterenol.
The peritoneal clearance of creatinine did not in-
crease, but that of inulin increased by some 25%.
When blood flow was controlled with an aortic
clamp, the inulin clearance returned to control lev-
els. These data are similar to those obtained with
isoproterenol, except that creatinine clearance was
unaffected by this agent. The data obtained in the
clamp experiments, the data obtained in the i.p.
glucagon study (6 gIml) where some dogs were
noted to have increased blood flow without any al-
teration in peritoneal clearances, and the constancy
of peritoneal clearance of creatinine in the i.v. stud-
ies all suggest that as with isoproterenol, glucagon
exerts its effects by a combination of events. Nei-
ther permeability effects alone or hemodynamic ef-
fects alone are sufficient to augment inulin clear-
ance.
The hypothesis which best satisfies these obser-
vations might be constructed as follows. When
glucagon is administered by the i.p. route, its rela-
tive lack of diffusion does not grant it access to the
splanchnic capillaries in high concentration, suf-
ficient to alter pore geometry. When given by the
i.v. route, it is present in sufficient concentration to
have two possible effects: (a) there is a change in
pore configuration such that the steric hindrance to
the passage of inulin is reduced; (b) alternatively,
there could be a change in pore geometry which
would favor diffusion of both creatinine and inulin.
As a result, however, of a blood flow-related in-
crease in area, the blood flow per effective area de-
creases, thus obviating or blunting an increment in
peritoneal clearance of creatinine. Only that of in-
ulin is perceived to increase; and this cannot occur
unless a direct permeability effect accompanies the
vasoactive effect. Why i.v. glucagon will cause an
increase in peritoneal clearance of inulin, whereas
i.v. isoproterenol will not, is unclear from our data,
but may be due to qualitative differences in the
vasodilator response to each agent. It is possible
that the increase in SMA flow with glucagon is ac-
companied by an increase in peritoneal membrane
capillary flow, whereas because of the recruitment
of low-resistance or "thoroughfare channels" the
administration of isoproterenol does not cause such
an association. Recently, other investigators, work-
ing with rabbits, have observed that i.p. glucagon is
less effective than i.v. administration in altering
peritoneal clearances [12].
The suggestion which we put forward, that vaso-
dilators act by a combination of effects, receives in-
direct support from recent studies carried out in rats
by Brown et al [14]. These investigators have dem-
onstrated that splanchnic vasodilators with known
membrane-permeability effects (bradykinin and his-
tamine) did not increase peritoneal clearance of
urea and inulin to any greater extent than did vaso-
dilators not known to possess permeability effects
(isoproterenol and nitroprusside). In other words, a
vasodilator such as isoproterenol seems to be acting
on the peritoneal membranes as if it possessed in-
herent membrane-permeability effects.
Finally, our experiments also indicate that a com-
monly ingested drug, salicylate, may have its clear-
ance modestly increased (23%) during peritoneal
dialysis, independent of any effects of nonionic dif-
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fusion. There is at present, however, insufficient
evidence to say whether parenteral or local vaso-
dilators should be routinely included with acute
peritoneal dialysis for more efficient exchange and
clearance of drugs or endogenous solute, or with
chronic dialysis for the treatment of uremia. It is
particularly important to emphasize that our find-
ings, derived from canine studies, should not un-
critically be extrapolated to the human situation.
Man and dog differ in how blood is supplied to the
splanchnic bed, especially with regard to collateral
flow, and conclusions derived from one labortory
species may not be true for the clinical situation
[27].
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